Page last updated: 2024-10-25

deferoxamine and Fetal Growth Restriction

deferoxamine has been researched along with Fetal Growth Restriction in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fozza, C1
Asara, MA1
Vacca, N1
Caggiari, S1
Monti, A1
Zaccheddu, F1
Capobianco, G1
Dessole, S1
Dore, F1
Antonucci, R1

Other Studies

1 other study available for deferoxamine and Fetal Growth Restriction

ArticleYear
Pregnancy Outcome among Women with Beta-Thalassemia Major in North Sardinia.
    Acta haematologica, 2017, Volume: 138, Issue:3

    Topics: Abortion, Spontaneous; Adult; Benzoates; beta-Thalassemia; Deferasirox; Deferoxamine; Diabetes, Gest

2017